Beijing: A Chinese healthcare platform has started selling Pfizer‘s oral COVID treatment pill Paxlovid in what appears to be the first retail sale of the drug in the country, as China braces for a surge in COVID patients. The medication sold out just over half an hour after the listing was reported in the media, … Read more
March 15, 2022 — The CEO of vaccine maker Pfizer made news over the weekend when he said people who have already gotten three shots of his company’s COVID-19 vaccine will need a fourth dose. Albert Bourla, PhD, said data the company has submitted to the FDA — but has not yet released publicly — … Read more
Nov. 2, 2021 — Younger children could soon receive their first dose of Pfizer’s COVID vaccine after the CDC officially endorsed the shot for this age group on Tuesday evening. CDC Director Rochelle Walensky, MD, signed off on the recommendation, which she was expected to do, meaning Pfizer’s vaccine could be available to kids within this age … Read more
Oct. 29, 2021 — The FDA has authorized Pfizer’s COVID-19 vaccine for children ages 5 to 11, which means vaccines could be available to school-aged children starting next week. The move brings families with young children a step closer to resuming their normal activities, and it should help further slow transmission of the coronavirus in the U.S. … Read more
Oct. 26, 2021 — The benefits of Pfizer’s COVID-19 vaccine for children ages 5 to 11 outweigh its risks, according to an independent panel of vaccine experts that advises the FDA. Seventeen of the 18 members of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Tuesday voted to recommend the 10-microgram shot for … Read more
By Sarah Jane Tribble, Kaiser Health News Wednesday, March 10, 2021 (Kaiser News) — Pfizer’s management knew last year there was “a mold issue” at the Kansas facility now slated to produce the drugmaker’s urgently needed covid-19 vaccine, according to a Food and Drug Administration inspection report. This story also ran on The Daily Beast. … Read more
By Arthur Allen Wednesday, November 11, 2020 (Kaiser News) — Pfizer’s announcement on Monday that its COVID-19 shot appears to keep nine in 10 people from getting the disease sent its stock price rocketing. Many news reports described the vaccine as if it were our deliverance from the pandemic, even though few details were … Read more